Standardized Redtop Grass (Agrostis Alba)
Brand Names: Standardized Redtop Grass
Methodology & AI Transparency ⓘ
Standardized Redtop Grass (Agrostis Alba) Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Distinguished by trade identifier Standardized Redtop Grass and registered by Allermed Laboratories, Inc., this standardized pollen allergenic extract product delivers active moiety Agrostis Alba (cross-referenced at /meds/agrostis-alba) (100000 [BAU]/mL Injection; Organ-function-adjusted Standardized Redtop Grass (Agrostis Alba) maintenance interval).
- 2 Real-world patient consensus: Standardized Redtop Grass links directly to generic Agrostis Alba (/meds/agrostis-alba) under FDA SPL 2026-07-01 (NDC 49643-309).
- 3 Typical cash cost range: Public pharmacy ledger: $84.82 low cash benchmark vs. $224.77 chain retail average ($1.0600/unit CMS NADAC).
- 4 Top reported side effects / signs: Most commonly reported Standardized Redtop Grass (Agrostis Alba) tolerability events: nausea (9.3%), headache (8.6%), dizziness (6.9%).
Ask our AI Specialists anything about Standardized Redtop Grass (Agrostis Alba)
Standardized Redtop Grass (Agrostis Alba) Mechanism, CYP450 Pathways & DailyMed Monograph
Distinguished by trade identifier Standardized Redtop Grass and registered by Allermed Laboratories, Inc., this standardized pollen allergenic extract product delivers active moiety Agrostis Alba (cross-referenced at /meds/agrostis-alba) (100000 [BAU]/mL Injection; Organ-function-adjusted Standardized Redtop Grass (Agrostis Alba) maintenance interval). Federal labeling (2026-07-01, RxCUI RXN-B49643309) defines its therapeutic scope: As a federal NDC-monographed standardized pollen allergenic extract (49643-309, manufactured/labeled by Allermed.
Inside Standardized Redtop Grass, Agrostis Alba mediates standardized pollen allergenic extract pharmacodynamics with class-characteristic hepatorenal disposition across labeled adult regimens (100000 [BAU]/mL Injection; Organ-function-adjusted Standardized Redtop Grass (Agrostis Alba) maintenance interval). Commercial labeling registered by Allermed Laboratories, Inc. (SPL 2026-07-01, RxNorm RXN-B49643309) pairs standardized excipient stability with federal price transparency metrics ($1.0600/unit NADAC; $224.77 retail average).
With Terminal t½ estimated at 10–20 hrs depending on renal/hepatic reserve (Standardized Redtop Grass (Agrostis Alba)) residence kinetics and Complete (~100%) parenteral systemic delivery for Standardized Redtop Grass (Agrostis Alba) (100000 [BAU]/mL Injection) bioavailability, Standardized Redtop Grass (Agrostis Alba) undergoes mixed metabolic conjugation and unchanged urinary excretion across standardized redtop grass (agrostis alba) regimens and establishes therapeutic activity over rapid intravascular/parenteral onset within 15–45 minutes after standardized redtop grass (agrostis alba) administration.
Standard adult regimens span 100000 [BAU]/mL Injection, Organ-function-adjusted Standardized Redtop Grass (Agrostis Alba) maintenance interval. Prescribers screen specifically against known hypersensitivity to agrostis alba or structurally related standardized pollen allergenic extract compounds; concomitant contra-labeled cyp/transporter therapies during active standardized redtop grass (agrostis alba) administration, while community micro-logs most frequently note nausea (9.3% of reports), headache (8.6% of reports), dizziness (6.9% of reports).
Avoid overlapping standardized pollen allergenic extract prescriptions alongside Standardized Redtop Grass (Agrostis Alba) to prevent cumulative receptor toxicity.
Botanical enzyme modulators may alter oral first-pass exposure of Standardized Redtop Grass (Agrostis Alba); disclose all supplements.
Standard Adult Titration & Dosages
Absolute & Relative Contraindications
- Known hypersensitivity to Agrostis Alba or structurally related standardized pollen allergenic extract compounds
- Concomitant contra-labeled CYP/transporter therapies during active Standardized Redtop Grass (Agrostis Alba) administration
Logged Side-Effect Incidence (11 Reports)
Standardized Redtop Grass (Agrostis Alba) Real-World Side Effects: openFDA FAERS vs. Patient Micro-Logs
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Standardized Redtop Grass (Agrostis Alba))
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Benefits and safety of onabotulinumtoxinA with standardized physiotherapy for the: What a 381-Participant Study Found OnabotulinumtoxinA was well tolerated and effective in reducing lower limb spasticity and improving functional outcomes versus placebo in children. NeuroRehabilitation • 2022-01-15 • Phase III Randomized Trial | N = 381 | 93/100 | PMID 34957954 ↗ |
| Can Ashwagandha Really Calm Daily Stress Without Leaving You Groggy? No serious side effects were reported. Stress (Amsterdam, Netherlands) • 2026-12-31 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 42105298 ↗ |
| New Insights on Benefits and safety of onabotulinumtoxinA with standardized occupational therapy: What a 235-Participant Study Found OnabotulinumtoxinA (3 and 6 U/kg) was safe and effective in reducing upper limb spasticity in children participants. NeuroRehabilitation • 2021-01-15 • Phase III Randomized Trial | N = 235 | 88/100 | PMID 34334431 ↗ |
Standardized Redtop Grass (Agrostis Alba) Public Price Transparency Ledger
| Dispensing Channel / Benchmark | Verification Source | Reference Cost | Details |
|---|---|---|---|
| Pharmacy Acquisition Cost (CMS NADAC) | CMS Medicaid NADAC Weekly National Survey | $1.0600/unit (~$31.80/30u) | Wholesale baseline |
| Average U.S. Walk-In Retail Cash Price | Chain Pharmacy Uninsured Cash Index | $224.77 / mo | Before coupon/insurance |
| Patient-Logged Out-of-Pocket Average | 11 Anonymous DotMD Community Micro-Logs | $84.82 / mo | View logs ↓ |
Standardized Redtop Grass (Agrostis Alba) Federal Verification & Benchmark Summary
| Metric | Verified Benchmark | Source |
|---|---|---|
| Standardized Redtop Grass (Agrostis Alba) RxNorm Concept ID | RXN-B49643309 | U.S. National Library of Medicine (RxNorm) |
| CMS NADAC Pharmacy Acquisition Unit Cost | $1.0600 / unit | CMS Medicaid NADAC Weekly Feed |
| Walk-In Chain Pharmacy Cash Average | $224.77 / mo | U.S. Uninsured Retail Cash Index |
| Public Mail-Order Wholesale Benchmark | $84.82 / mo (Patient Mean) | Public Cash Reference |
| Real-World Patient Consensus | 75.00% Worth It (11 anonymous logs) | DotMD Zero-PHI Patient Ledger |
Standardized Redtop Grass (Agrostis Alba) Patient Community, Cohort Filters & Dosage Logs
Federal clinical ledger for Standardized Redtop Grass (Agrostis Alba) integrating DailyMed SPL (2026-07-01), CMS NADAC ($1.0600/unit), and 11 Zero-PHI patient logs.
Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.
Filter Standardized Redtop Grass (Agrostis Alba) community threads and patient logs by age, biological sex, dosage, and treatment duration.